Is the point that the US is a big chunk of the developed world, so the company can't afford with that cut out? Or is the implication of this that the super-high costs of healthcare in the US are actually good for everyone else, because they end up as an effective subsidy for drug development?
add a skeleton here at some point
4 days ago